Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GB17410/74AGB1508977A (en) | 1974-04-20 | 1974-04-20 | Beta-lactam antibiotic from streptomyces clavuligerus |
IE792/75AIE41109B1 (en) | 1974-04-20 | 1975-04-08 | Novel -lactam antibiotic from streptomyces clavuligerus |
IE1987/78AIE41110B1 (en) | 1974-04-20 | 1975-04-08 | Esters of clavulanic acid |
NZ177159ANZ177159A (en) | 1974-04-20 | 1975-04-08 | Clavulanic acid, salts, esters and preparation thereof from streptomyces clavuligerus: pharmaceutical compositions |
YU908/75AYU39941B (en) | 1974-04-20 | 1975-04-09 | Process for obtaining clavulanic acid |
FR7511344AFR2267778B1 (en) | 1974-04-20 | 1975-04-11 | |
CY1078ACY1078A (en) | 1974-04-20 | 1975-04-11 | Beta-lactam antibiotic from strepomyces clavuligerus |
BE155402ABE827926A (en) | 1974-04-20 | 1975-04-14 | ANTIBIOTIC |
IN743/CAL/75AIN140042B (en) | 1974-04-20 | 1975-04-14 | |
IL47087AIL47087A (en) | 1974-04-20 | 1975-04-14 | Antibiotic compounds obtained from streptomyces clavuligerus their preparation and pharmaceutical compositions containig them |
AU80177/75AAU499171B2 (en) | 1973-05-04 | 1975-04-15 | Clavulanic acid derivatives |
FI751133AFI54144C (en) | 1974-04-20 | 1975-04-16 | FOERFARANDE FOER FRAMSTAELLNING AV KLAVULANSYRA ELLER ETT SALT DAERAV |
SU752129801ASU648117A3 (en) | 1974-04-20 | 1975-04-18 | Method of obtaining antibacterial substance |
DD7500193531ADD132297A5 (en) | 1974-04-20 | 1975-04-18 | METHOD FOR PRODUCING A SYNERGISTIC PHARMACEUTICAL AGENT |
DE2559411ADE2559411C2 (en) | 1974-04-20 | 1975-04-18 | Use of clavulanic acid |
LU72322ALU72322A1 (en) | 1974-04-20 | 1975-04-18 | |
MX513175UMX3973E (en) | 1974-04-20 | 1975-04-18 | PROCEDURE FOR THE PREPARATION OF CLAVULANIC ACID ESTERS |
DE2560074ADE2560074C2 (en) | 1974-04-20 | 1975-04-18 | Process for the production of clavulanic acid and its salts |
CS752721ACS231157B2 (en) | 1974-04-20 | 1975-04-18 | Processing method of klavulan acid and corresponding salts and esters |
MX513075UMX4009E (en) | 1974-04-20 | 1975-04-18 | PROCEDURE FOR THE PREPARATION OF CLAVANIC ACID ESTERS |
DK167275AADK141254B (en) | 1974-04-20 | 1975-04-18 | Process for preparing clavulanic acid or a salt or ester thereof. |
ES436766AES436766A1 (en) | 1974-04-20 | 1975-04-18 | A procedure for the preparation of a clavulan acid salt. (Machine-translation by Google Translate, not legally binding) |
ZA00752492AZA752492B (en) | 1974-04-20 | 1975-04-18 | Antibiotics |
NL7504621.ANL163824C (en) | 1974-04-20 | 1975-04-18 | PROCESS FOR THE RECOVERY OF AN ANTIBIOTIC WITH AN EFFICIENCY AGAINST BACTERIA CALLED CLAVULANIC ACID, PROCESS FOR PREPARING PHARMACEUTICAL PREPARATIONS CONTAINING THIS ANTIBIOTIC PRODUCT OR A SALT OR ESTER PREPARED THEREFORE, INCLUDING PREPARATIONS |
AR258435AAR206627A1 (en) | 1974-04-20 | 1975-04-18 | PROCEDURE FOR THE PREPARATION OF CALVULANIC ACID |
HU75BE1267AHU173700B (en) | 1974-04-20 | 1975-04-18 | Process for producing esters of clavulanic acid |
NO751407ANO145247C (en) | 1974-04-20 | 1975-04-18 | PROCEDURE FOR THE PREPARATION OF CLAVULANIC ACID |
AT298575AAT352270B (en) | 1974-04-20 | 1975-04-18 | METHOD FOR PRODUCING THE NEW CLAVULANIC ACIDS |
DD185542ADD121799A5 (en) | 1974-04-20 | 1975-04-18 | |
DE2517316ADE2517316C2 (en) | 1974-04-20 | 1975-04-18 | Clavulanic acid and its salts and medicinal products containing these compounds |
DE19752559410DE2559410A1 (en) | 1974-04-20 | 1975-04-18 | ESTERS OF CLAVULANIC ACIDS, THE PROCESS FOR THEIR MANUFACTURING AND MEDICINAL PRODUCTS CONTAINING THESE COMPOUNDS |
CA224,970ACA1059050A (en) | 1974-04-20 | 1975-04-18 | Clavulanic acid from streptomyces clavuligerus |
SE7504541ASE422063B (en) | 1974-04-20 | 1975-04-18 | PROCEDURE FOR PREPARING ANIBIOTICS FROM S.CLOVULIGERUS |
JP50048087AJPS5246957B2 (en) | 1974-04-20 | 1975-04-19 | |
JP50048086AJPS521996B2 (en) | 1974-04-20 | 1975-04-19 | |
OA55480AOA05203A (en) | 1974-04-20 | 1975-04-19 | New Antibiotics. |
EG33575AEG12445A (en) | 1974-04-20 | 1975-04-19 | Process for preparing of antibiotics |
RO7582037ARO69984A (en) | 1974-04-20 | 1975-04-19 | CLAVULIAN ACID PROCESSING PROCEDURE |
RO7595311ARO77320A (en) | 1974-04-20 | 1975-04-19 | PROCEDURE FOR THE PURIFICATION OF CLAVULANIC ACID SALTS |
CH506075ACH629252A5 (en) | 1974-04-20 | 1975-04-21 | METHOD FOR THE PRODUCTION OF CLAVULANIC ACID AND ITS SALTS. |
PH17082APH16474A (en) | 1974-04-20 | 1975-04-21 | Clavulcanic acid,salts and esters thereof and pharmaceutical compositions containing same |
AR261404AAR219050A1 (en) | 1974-04-20 | 1975-11-28 | PROCEDURE FOR THE PREPARATION OF ESTERS OF THE CLAVULANIC ACID |
AR261403AAR216430A1 (en) | 1974-04-20 | 1975-11-28 | A PROCEDURE FOR THE PREPARATION OF CLAVULANIC ACID ESTERS |
US05/726,061US4110165A (en) | 1974-04-20 | 1976-09-24 | Process for the production of clavulanic acid |
US06/726,224US4427690A (en) | 1974-04-20 | 1976-09-24 | Esters of clavulanic acid |
JP16090276AJPS5285189A (en) | 1974-04-20 | 1976-12-28 | Process for preparing antibiotics |
AT205377AAT353407B (en) | 1974-04-20 | 1977-03-24 | METHOD FOR PREPARING SYNERGISTIC ANTIBACTERIAL COMPOSITIONS |
AT205277AAT350718B (en) | 1974-04-20 | 1977-03-24 | PROCESS FOR THE PRODUCTION OF NEW CLAVULAN ACID ESTERS |
AT205477AAT350719B (en) | 1974-04-20 | 1977-03-24 | PROCESS FOR THE PRODUCTION OF NEW SALT OF CLAVULANIC ACID |
AT205577AAT348124B (en) | 1974-04-20 | 1977-03-24 | PROCESS FOR THE PRODUCTION OF NEW CLAVULAN ACID SALT |
JP4026177AJPS533590A (en) | 1974-04-20 | 1977-04-05 | Purification of antibiotic |
JP4026077AJPS533589A (en) | 1974-04-20 | 1977-04-05 | Purification of antibiotic |
JP4025977AJPS533588A (en) | 1974-04-20 | 1977-04-05 | Production of antibiotic |
JP4025877AJPS532495A (en) | 1974-04-20 | 1977-04-05 | Method of purifying antibiotics |
JP4025777AJPS532494A (en) | 1974-04-20 | 1977-04-05 | Process for preparing antibiotics |
FI780201AFI58332C (en) | 1974-04-20 | 1978-01-23 | FOERFARANDE FOER FRAMSTAELLNING AV ESTRAR AV KLAVULANSYRA |
FI780202AFI780202A (en) | 1974-04-20 | 1978-01-23 | FOERFARANDE FOER FRAMSTAELLNING AV ETT HUVUDSAKLIGEN RENT SALT AV KLAVULANCY |
DK287378ADK150489C (en) | 1974-04-20 | 1978-06-26 | PROCEDURE FOR PREPARING A CLAVULANIC ACID SAL |
DK287078ADK145543C (en) | 1974-04-20 | 1978-06-26 | PROCEDURE FOR THE PREPARATION OF HYDRAULIZABLE ESTERS OF CLAVULANIC ACID |
DK287278ADK150488C (en) | 1974-04-20 | 1978-06-26 | PROCEDURE FOR INSULATING A CLAVULANIC ACID SAL |
DK287178ADK287178A (en) | 1974-04-20 | 1978-06-26 | PROCEDURE FOR PREPARING AN ANTIBIOTIC |
US05/924,174US4556559A (en) | 1974-04-20 | 1978-07-13 | Antibiotics |
SE7811200ASE435286B (en) | 1974-04-20 | 1978-10-27 | CLAVULANIC ACID FOR USE AS A CHEMICAL INTERMEDIATE IN THE PRODUCTION OF CLAVULANIC ACID DERIVATIVES |
SE7811201ASE446687B (en) | 1974-04-20 | 1978-10-27 | PROCEDURE FOR PREPARING AN ANTIBACTERIAL, PHARMACEUTICAL PREPARATION WITH SYNERGISTIC EFFECT, INCLUDING CLAVULANIC ACID |
SE7811203ASE443562B (en) | 1974-04-20 | 1978-10-27 | PROCEDURE FOR PREPARING A PURE SALT OF CLAVULANIC ACID |
SE7811202ASE435287B (en) | 1974-04-20 | 1978-10-27 | ANALOGY PROCEDURE FOR THE PREPARATION OF CLAVULANIC ACID ESTERS |
CA314,882ACA1076120A (en) | 1974-04-20 | 1978-10-30 | Clavulanic acid esters |
CA314,881ACA1074325A (en) | 1974-04-20 | 1978-10-30 | Clavulanic acid and its salts |
CA314,880ACA1055395A (en) | 1974-04-20 | 1978-10-30 | Antibiotics |
NO791956ANO150838C (en) | 1974-04-20 | 1979-06-12 | ANALOGY PROCEDURE FOR THE PREPARATION OF NEW CLAVULANIC ACID COMPOUNDS WITH ANTIBACTERIAL AND BETA-LACTAMASE INHIBITIVE PROPERTIES |
NO801852ANO801852L (en) | 1974-04-20 | 1980-06-20 | PHARMACEUTICAL CLAVULANIC ACID. |
DK286980ADK157302C (en) | 1974-04-20 | 1980-07-02 | ESTERS OF CLAVULANIC ACID USED AS INTERMEDIATES IN THE PRODUCTION OF CLAVULANIC ACID OR PHARMACEUTICAL TOLERABLE SALTS THEREOF |
KE3076AKE3076A (en) | 1974-04-20 | 1980-08-29 | Novel b-lactam antibiotic from streptomyces clavuligerus |
HK547/80AHK54780A (en) | 1974-04-20 | 1980-09-25 | Novel b-lactam antibiotic from streptomyces clavuligerus |
CH947280ACH630631A5 (en) | 1974-04-20 | 1980-12-22 | METHOD FOR PRODUCING CLAVULANIC ACID ESTERS AND THE USE THEREOF FOR PRODUCING CLAVULANIC ACID AND ITS SALTS. |
US06/272,030US4526783A (en) | 1974-04-20 | 1981-06-09 | Antibiotic from S. clavuligerus |
US06/305,337US4529720A (en) | 1974-04-20 | 1981-09-24 | Antibiotic from Streptomyces clavulicerus |
SE8105829ASE453600B (en) | 1974-04-20 | 1981-10-02 | PROCEDURE FOR PREPARING A SALT OF CLAVULANIC ACID |
YU2743/81AYU42744B (en) | 1974-04-20 | 1981-11-23 | Process for obtaining clavulinic acid esthers |
YU2744/81AYU42745B (en) | 1974-04-20 | 1981-11-23 | Process for obtaining clavulinic acid esthers |
US06/327,253US4525352A (en) | 1974-04-20 | 1981-12-03 | Antibiotics |
US06330456US4560552C1 (en) | 1974-04-20 | 1981-12-14 | Antibiotics |
MY195/81AMY8100195A (en) | 1974-04-20 | 1981-12-30 | Novel b-lactam antibiotic from streptomyes clavuligerus |
US06/352,951US4525353A (en) | 1974-04-20 | 1982-02-26 | Antibiotics |
SE8306328ASE8306328D0 (en) | 1974-04-20 | 1983-11-16 | ESTARS OF CLAVULANIC ACID |
SE8605405ASE8605405D0 (en) | 1974-04-20 | 1986-12-16 | PROCEDURE FOR PREPARING A SALT OF CLAVULANIC ACID |
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GB17410/74AGB1508977A (en) | 1974-04-20 | 1974-04-20 | Beta-lactam antibiotic from streptomyces clavuligerus |
Publication Number | Publication Date |
---|---|
GB1508977Atrue GB1508977A (en) | 1978-04-26 |
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
GB17410/74AExpiredGB1508977A (en) | 1973-05-04 | 1974-04-20 | Beta-lactam antibiotic from streptomyces clavuligerus |
Country | Link |
---|---|
AT (1) | AT352270B (en) |
BE (1) | BE827926A (en) |
CS (1) | CS231157B2 (en) |
GB (1) | GB1508977A (en) |
SU (1) | SU648117A3 (en) |
ZA (1) | ZA752492B (en) |
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0008525A2 (en)* | 1978-08-25 | 1980-03-05 | Beecham Group Plc | Pharmaceutical compositions and process for their preparation |
JPS5559108A (en)* | 1978-10-27 | 1980-05-02 | Beecham Group Ltd | Mammary gland composition |
EP0026044B1 (en)* | 1979-08-24 | 1983-06-08 | Beecham Group Plc | Amine salt of clavulanic acid, its preparation and use |
GB2200355A (en)* | 1987-01-29 | 1988-08-03 | Beecham Group Plc | Potassium clavulanate |
EP0182522B1 (en)* | 1984-10-27 | 1991-06-19 | Beecham Group p.l.c. | Preparation of clavulanic acid and its salts and esters |
US5288861A (en)* | 1987-01-29 | 1994-02-22 | Beecham Group Plc | Potassium clavulanate in rosette form |
EP0594099A1 (en)* | 1992-10-21 | 1994-04-27 | Pharma Development Ltd. | Process for the purification of crude clavulanic acid |
EP0672669A1 (en) | 1992-06-11 | 1995-09-20 | Smithkline Beecham Plc | Process for the preparation of clavulanic acid |
US5498788A (en)* | 1992-07-08 | 1996-03-12 | Lek, Tovarna Farmacevtskih | Inclusion complexes of clavulanic acid and of potassium salts thereof with hydrophobic β-cyclodextrin derivatives a process for the preparation thereof |
WO1996018743A1 (en)* | 1994-12-10 | 1996-06-20 | Smithkline Beecham Plc | Process for the fermentative preparation of clavam derivatives whereby the levels of ammonia and urea in the fermentation medium are kept low |
WO1996028452A1 (en) | 1995-03-10 | 1996-09-19 | Lek Pharmaceutical And Chemical Co. D.D. | Process for the preparation of pharmaceutically acceptable salts of clavulanic acid |
JPH08511010A (en)* | 1993-06-07 | 1996-11-19 | バイエル・アクチエンゲゼルシヤフト | Cyclobutylazole |
WO1997008175A1 (en)* | 1995-08-28 | 1997-03-06 | Lek Pharmaceutical & Chemical Co. Dd | Isolation of clavulanic acid from fermentation broth by ultrafiltration |
EP0761218A1 (en) | 1994-04-23 | 1997-03-12 | Smithkline Beecham Corporation | Process for preparing polymer coated tablet comprising amoxycillin and clavunalate |
WO1997019187A1 (en)* | 1995-11-23 | 1997-05-29 | Antibioticos, S.A. | Process for the production of clavulanic acid and/or salts thereof |
US5726170A (en)* | 1995-02-25 | 1998-03-10 | Spurcourt Limited | Clavulanic acid salts |
US5734048A (en)* | 1995-05-16 | 1998-03-31 | Chong Kun Dang Corp. | Process for manufacturing clavulanic acid salt |
US5750685A (en)* | 1987-01-29 | 1998-05-12 | Smithkline Beecham, P.L.C. | Process for preparing potassium clavulanate in rossette form |
US5859238A (en)* | 1992-03-26 | 1999-01-12 | Lek, Tovarna Farmacevtskih | Alkylenediammonium diclavulanate derivatives, a process for the preparation thereof as well as the use thereof |
US5985625A (en)* | 1994-03-02 | 1999-11-16 | Lek Pharmaceutical & Chemical Co. Dd | Process for the isolation of clavulanic acid and of pharmaceutically acceptable salts thereof from the fermentation broth of Streptomyces sp. P 6621 FERM P 2804 |
WO2001012171A2 (en)* | 1999-08-16 | 2001-02-22 | Revaax Pharmaceuticals, Llc | Pharmaceutical compositions comprising clavulanic acid or derivative thereof for the treatment of behavioral diseases |
US6194001B1 (en) | 1996-08-06 | 2001-02-27 | Quadrant Holdings Cambridge Ltd. | Tablet dosage form of clavulanic acid and amoxycillin comprising a trehalose excipient |
EP0741732B1 (en)* | 1994-02-02 | 2001-06-20 | Smithkline Beecham Plc | Process for the preparation of a salt of clavulanic acid |
US6414142B1 (en)* | 1996-06-13 | 2002-07-02 | Smithkline Beecham Corporation | Process for preparing potassium clavulanate |
US6426342B2 (en) | 1999-08-16 | 2002-07-30 | Revaax Pharmaceuticals, Llc | Use of β-lactamase inhibitors as neuroprotectants |
US6489319B2 (en) | 1999-08-16 | 2002-12-03 | Revaax Pharmaceuticals, Llc | Neurotherapeutic use of carboxypeptidase inhibitors |
EP0941229B1 (en)* | 1996-11-27 | 2003-09-03 | BIOCHEMIE Gesellschaft m.b.H. | Purification of fermented clavulanic acid |
US6660299B2 (en) | 1999-04-13 | 2003-12-09 | Beecham Pharmaceuticals Limited | Modified release pharmaceutical formulation comprising amoxycillin |
US6746692B2 (en) | 1999-04-13 | 2004-06-08 | Beecham Pharmaceuticals (Pte) Limited | Modified release pharmaceutical formulation comprising amoxycillin |
US6756057B2 (en) | 2000-10-12 | 2004-06-29 | Beecham Pharmaceuticals (Pte) Limited | Amoxicillin and potassium clavulanate dosage form |
US6783773B1 (en) | 1999-04-13 | 2004-08-31 | Beecham Pharmaceuticals (Pte) Limited | Composition comprising amoxicillin and potassium clavulanate |
US7011849B2 (en) | 2000-10-12 | 2006-03-14 | Beecham Pharmaceuticals (Pte) Limited | Second release phase formulation |
USH2158H1 (en) | 1992-03-10 | 2006-06-06 | Sandoz Ag | Process for the production of clavulanic acid salts |
US7767823B2 (en) | 2000-05-13 | 2010-08-03 | Smithkline Beecham Limited | Process for the purification of a salt of clavulanic acid |
ES2357595A1 (en)* | 2009-10-02 | 2011-04-28 | Instituto Mediterraneo Para El Avance De La Biotecnologia Y La Investigacion Sanitaria (Fundacion Im | CLAVULANIC ACID COMPOSITION AND USE FOR DIAGNOSIS IN ALLERGOLOGY. |
WO2011078820A1 (en) | 2009-12-25 | 2011-06-30 | Mahmut Bilgic | Pharmaceutical formulations comprising a third generation cephalosporin and clavulanic acid |
WO2011093829A1 (en) | 2010-01-29 | 2011-08-04 | Mahmut Bilgic | Effervescent formulations comprising cefixime and clavulanic acid as active agents |
WO2011093827A1 (en) | 2010-01-29 | 2011-08-04 | Mahmut Bilgic | Water dispersible cefdinir and clavulanic acid formulations for treatment of bacterial infections |
WO2011093826A2 (en) | 2010-01-29 | 2011-08-04 | Mahmut Bilgic | Effervescent formulations comprising cefaclor and clavulanic acid as active agents |
CN115433701A (en)* | 2022-11-08 | 2022-12-06 | 南京农业大学 | A strain of Proteus and its agent and its application in degrading cephalosporin antibiotics |
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4098897A (en) | 1975-04-14 | 1978-07-04 | Beecham Group Limited | Anti bacterial agents |
IE44295B1 (en)* | 1975-10-13 | 1981-10-07 | Beecham Group Ltd | Clavulanic acid derivatives |
GB1582884A (en)* | 1977-05-19 | 1981-01-14 | Beecham Group Ltd | Clavulanic acid derivatives their preparation and use |
US4454069A (en)* | 1979-08-24 | 1984-06-12 | Beecham Group Limited | Clavulanic acid salts and their preparation from the tertiary butyl amine salt |
EP2589663A1 (en) | 2011-11-04 | 2013-05-08 | LEK Pharmaceuticals d.d. | Process for production of clavulanic acid |
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0008525A3 (en)* | 1978-08-25 | 1980-05-28 | Beecham Group Plc | Pharmaceutical compositions and process for their preparation |
EP0008525A2 (en)* | 1978-08-25 | 1980-03-05 | Beecham Group Plc | Pharmaceutical compositions and process for their preparation |
JPH0223530B2 (en)* | 1978-10-27 | 1990-05-24 | Beecham Group Plc | |
JPS5559108A (en)* | 1978-10-27 | 1980-05-02 | Beecham Group Ltd | Mammary gland composition |
EP0010904A2 (en)* | 1978-10-27 | 1980-05-14 | Beecham Group Plc | Intramammary compositions and process for their preparation |
EP0010904A3 (en)* | 1978-10-27 | 1980-07-23 | Beecham Group Limited | Intramammary compositions and process for their preparation |
EP0026044B1 (en)* | 1979-08-24 | 1983-06-08 | Beecham Group Plc | Amine salt of clavulanic acid, its preparation and use |
EP0182522B1 (en)* | 1984-10-27 | 1991-06-19 | Beecham Group p.l.c. | Preparation of clavulanic acid and its salts and esters |
GB2200355A (en)* | 1987-01-29 | 1988-08-03 | Beecham Group Plc | Potassium clavulanate |
GB2200355B (en)* | 1987-01-29 | 1990-08-01 | Beecham Group Plc | Potassium clavulanate |
EP0277008A1 (en)* | 1987-01-29 | 1988-08-03 | Beecham Group Plc | Process for crystallization of potassium clavulanate |
US5288861A (en)* | 1987-01-29 | 1994-02-22 | Beecham Group Plc | Potassium clavulanate in rosette form |
US5750685A (en)* | 1987-01-29 | 1998-05-12 | Smithkline Beecham, P.L.C. | Process for preparing potassium clavulanate in rossette form |
USH2158H1 (en) | 1992-03-10 | 2006-06-06 | Sandoz Ag | Process for the production of clavulanic acid salts |
US5859238A (en)* | 1992-03-26 | 1999-01-12 | Lek, Tovarna Farmacevtskih | Alkylenediammonium diclavulanate derivatives, a process for the preparation thereof as well as the use thereof |
EP0672670A1 (en) | 1992-06-11 | 1995-09-20 | Smithkline Beecham Plc | Process for the preparation of clavulanic acid |
EP0699682A1 (en) | 1992-06-11 | 1996-03-06 | Smithkline Beecham P.L.C. | Process for the preparation and/or purification of clavulanic acid |
DE4345311C1 (en)* | 1992-06-11 | 1996-02-01 | Smithkline Beecham Plc | Process for the production and / or purification of clavulanic acid |
EP0801069A1 (en)* | 1992-06-11 | 1997-10-15 | Smithkline Beecham Plc | Process for the preparation of clavulanic acid |
EP0672669A1 (en) | 1992-06-11 | 1995-09-20 | Smithkline Beecham Plc | Process for the preparation of clavulanic acid |
EP0806426A1 (en)* | 1992-06-11 | 1997-11-12 | Smithkline Beecham Plc | Process for the preparation of clavulanic acid |
EP0672669B1 (en)* | 1992-06-11 | 1997-09-10 | Smithkline Beecham Plc | Process for the preparation of potassium clavulanate |
US5498788A (en)* | 1992-07-08 | 1996-03-12 | Lek, Tovarna Farmacevtskih | Inclusion complexes of clavulanic acid and of potassium salts thereof with hydrophobic β-cyclodextrin derivatives a process for the preparation thereof |
US5608052A (en)* | 1992-07-08 | 1997-03-04 | Lek, Tovarna Farmacevtskih In Kemicnih | Inclusioin complexes of clavulanic acid and of alkali salts thereof with hydrophilic and hydrophobic beta-cyclodextrin derivatives, a process for the preparation thereof and the use thereof |
US5614199A (en)* | 1992-07-08 | 1997-03-25 | Lek, Tovarna Farmacevtskih In Kemicnih Izdelkov, D.D., Ljubljana | Inclusion complexes of clavulanic acid and of alkali salts thereof with hydrophilic and hydrophobic β-cyclodextrin derivatives, a process for the preparation thereof and the use thereof |
EP0594099A1 (en)* | 1992-10-21 | 1994-04-27 | Pharma Development Ltd. | Process for the purification of crude clavulanic acid |
JPH08511010A (en)* | 1993-06-07 | 1996-11-19 | バイエル・アクチエンゲゼルシヤフト | Cyclobutylazole |
EP0741732B1 (en)* | 1994-02-02 | 2001-06-20 | Smithkline Beecham Plc | Process for the preparation of a salt of clavulanic acid |
US5985625A (en)* | 1994-03-02 | 1999-11-16 | Lek Pharmaceutical & Chemical Co. Dd | Process for the isolation of clavulanic acid and of pharmaceutically acceptable salts thereof from the fermentation broth of Streptomyces sp. P 6621 FERM P 2804 |
EP0761218A1 (en) | 1994-04-23 | 1997-03-12 | Smithkline Beecham Corporation | Process for preparing polymer coated tablet comprising amoxycillin and clavunalate |
US6235506B1 (en) | 1994-12-10 | 2001-05-22 | Smithkline Beecham, P.L.C. | Process for the fermentative preparation of clavam derivatives whereby the levels of ammonia and urea in the fermentation medium are kept low |
US5985624A (en)* | 1994-12-10 | 1999-11-16 | Smithkline Beecham P.L.C. | Process for the fermentative preparation of clavam derivatives whereby the levels of ammonia and urea in the fermentation medium are kept low |
CN1119423C (en)* | 1994-12-10 | 2003-08-27 | 史密丝克莱恩比彻姆有限公司 | Process for fermentative prepn. of clavam derivatives whereby the levels of ammonia and urea in the fermentation medium are kept low |
WO1996018743A1 (en)* | 1994-12-10 | 1996-06-20 | Smithkline Beecham Plc | Process for the fermentative preparation of clavam derivatives whereby the levels of ammonia and urea in the fermentation medium are kept low |
US5726170A (en)* | 1995-02-25 | 1998-03-10 | Spurcourt Limited | Clavulanic acid salts |
WO1996028452A1 (en) | 1995-03-10 | 1996-09-19 | Lek Pharmaceutical And Chemical Co. D.D. | Process for the preparation of pharmaceutically acceptable salts of clavulanic acid |
US5994534A (en)* | 1995-03-10 | 1999-11-30 | Lek Pharmaceutical And Chemical Co. D.D | Process for the preparation of pharmaceutically acceptable salts of clavulanic acid |
US5734048A (en)* | 1995-05-16 | 1998-03-31 | Chong Kun Dang Corp. | Process for manufacturing clavulanic acid salt |
CN1101396C (en)* | 1995-08-28 | 2003-02-12 | 莱柯·药品及化学制品公司 | Isolation of clavulanic acid from fermentation broth by ultrafiltration |
US6127358A (en)* | 1995-08-28 | 2000-10-03 | Urquhart-Dykes & Lord | Isolation of clavulanic acid from fermentation broth by ultrafiltration |
WO1997008175A1 (en)* | 1995-08-28 | 1997-03-06 | Lek Pharmaceutical & Chemical Co. Dd | Isolation of clavulanic acid from fermentation broth by ultrafiltration |
US6274575B1 (en) | 1995-08-28 | 2001-08-14 | Lek Pharmaceutical And Chemical Co. D. D. | Isolation of clavulanic acid from fermentation broth by ultrafiltration |
CN1113965C (en)* | 1995-11-23 | 2003-07-09 | 抗生素股份公司 | Process for production of clavulanic acid and/or salts thereof |
US6100052A (en)* | 1995-11-23 | 2000-08-08 | Antibioticos, S.A. | Process for the production of clavulanic acid and/or salts thereof by fermentation controlling soluble phosphate concentration |
WO1997019187A1 (en)* | 1995-11-23 | 1997-05-29 | Antibioticos, S.A. | Process for the production of clavulanic acid and/or salts thereof |
ES2101658A1 (en)* | 1995-11-23 | 1997-07-01 | Antibioticos Sa | Process for the production of clavulanic acid and/or salts thereof |
US6414142B1 (en)* | 1996-06-13 | 2002-07-02 | Smithkline Beecham Corporation | Process for preparing potassium clavulanate |
US6194001B1 (en) | 1996-08-06 | 2001-02-27 | Quadrant Holdings Cambridge Ltd. | Tablet dosage form of clavulanic acid and amoxycillin comprising a trehalose excipient |
EP0941229B1 (en)* | 1996-11-27 | 2003-09-03 | BIOCHEMIE Gesellschaft m.b.H. | Purification of fermented clavulanic acid |
US6878386B1 (en) | 1999-04-13 | 2005-04-12 | Beecham Pharmaceuticals (Pte) Limited | Method of treating a bacterial infection comprising amoxycillin and potassium clavulanate |
US6660299B2 (en) | 1999-04-13 | 2003-12-09 | Beecham Pharmaceuticals Limited | Modified release pharmaceutical formulation comprising amoxycillin |
US6783773B1 (en) | 1999-04-13 | 2004-08-31 | Beecham Pharmaceuticals (Pte) Limited | Composition comprising amoxicillin and potassium clavulanate |
US7250176B1 (en) | 1999-04-13 | 2007-07-31 | Beecham Pharmaceuticals (Pte) Limited | Method of treating a bacterial infection |
US6746692B2 (en) | 1999-04-13 | 2004-06-08 | Beecham Pharmaceuticals (Pte) Limited | Modified release pharmaceutical formulation comprising amoxycillin |
WO2001012171A2 (en)* | 1999-08-16 | 2001-02-22 | Revaax Pharmaceuticals, Llc | Pharmaceutical compositions comprising clavulanic acid or derivative thereof for the treatment of behavioral diseases |
WO2001012171A3 (en)* | 1999-08-16 | 2002-01-17 | Revaax Pharmaceuticals Llc | Pharmaceutical compositions comprising clavulanic acid or derivative thereof for the treatment of behavioral diseases |
US7842683B2 (en)* | 1999-08-16 | 2010-11-30 | Revaax Pharmaceuticals, Llc | Neurotherapeutic compositions and method |
US6610681B1 (en) | 1999-08-16 | 2003-08-26 | Revaax Pharmaceuticals, Llc | Neurotherapeutic clavulanate composition and method |
US6489319B2 (en) | 1999-08-16 | 2002-12-03 | Revaax Pharmaceuticals, Llc | Neurotherapeutic use of carboxypeptidase inhibitors |
US6627625B1 (en) | 1999-08-16 | 2003-09-30 | Revaax Pharmaceuticals, Llc | Treatment of behavioral disorders with β-lactam compounds |
US6426342B2 (en) | 1999-08-16 | 2002-07-30 | Revaax Pharmaceuticals, Llc | Use of β-lactamase inhibitors as neuroprotectants |
US7767823B2 (en) | 2000-05-13 | 2010-08-03 | Smithkline Beecham Limited | Process for the purification of a salt of clavulanic acid |
US7011849B2 (en) | 2000-10-12 | 2006-03-14 | Beecham Pharmaceuticals (Pte) Limited | Second release phase formulation |
US6756057B2 (en) | 2000-10-12 | 2004-06-29 | Beecham Pharmaceuticals (Pte) Limited | Amoxicillin and potassium clavulanate dosage form |
ES2357595A1 (en)* | 2009-10-02 | 2011-04-28 | Instituto Mediterraneo Para El Avance De La Biotecnologia Y La Investigacion Sanitaria (Fundacion Im | CLAVULANIC ACID COMPOSITION AND USE FOR DIAGNOSIS IN ALLERGOLOGY. |
WO2011078820A1 (en) | 2009-12-25 | 2011-06-30 | Mahmut Bilgic | Pharmaceutical formulations comprising a third generation cephalosporin and clavulanic acid |
WO2011093829A1 (en) | 2010-01-29 | 2011-08-04 | Mahmut Bilgic | Effervescent formulations comprising cefixime and clavulanic acid as active agents |
WO2011093827A1 (en) | 2010-01-29 | 2011-08-04 | Mahmut Bilgic | Water dispersible cefdinir and clavulanic acid formulations for treatment of bacterial infections |
WO2011093826A2 (en) | 2010-01-29 | 2011-08-04 | Mahmut Bilgic | Effervescent formulations comprising cefaclor and clavulanic acid as active agents |
CN115433701A (en)* | 2022-11-08 | 2022-12-06 | 南京农业大学 | A strain of Proteus and its agent and its application in degrading cephalosporin antibiotics |
Publication number | Publication date |
---|---|
ZA752492B (en) | 1976-06-30 |
BE827926A (en) | 1975-10-14 |
SU648117A3 (en) | 1979-02-15 |
ATA298575A (en) | 1979-02-15 |
CS231157B2 (en) | 1984-10-15 |
CS272175A2 (en) | 1984-02-13 |
AT352270B (en) | 1979-09-10 |
Publication | Publication Date | Title |
---|---|---|
GB1508977A (en) | Beta-lactam antibiotic from streptomyces clavuligerus | |
US4650795A (en) | Amine salts of clavulanic acid as antibacterial agents | |
IE41109B1 (en) | Novel -lactam antibiotic from streptomyces clavuligerus | |
KR950703346A (en) | Crystalline Penicillin Derivatives, Their Preparation and Uses (Crystalline Penicillin Derivative, and Its Production and Use) | |
GB1221855A (en) | Penicillin and cephalosporin derivatives | |
US4438101A (en) | Antibiotics | |
GB1505885A (en) | Substituted cephalosporins | |
GB1515241A (en) | Beta-lactam antibiotics | |
IE39216L (en) | Pharmaceutical tablets | |
US4428958A (en) | Therapeutic compounds containing β-lactams | |
GB1508978A (en) | Esters of clavulanic acid | |
US5049384A (en) | Antibacterial composition for medical use and a process for the preparation thereof | |
GB1311498A (en) | Penicillin and cephalosporin derivatives | |
ES461691A1 (en) | Beta-lactam antibiotics | |
GB1377661A (en) | Oxofuryl ester derivatives of penicillin and cephalosporin | |
US4524073A (en) | β-Lactam compounds | |
EP0055062B1 (en) | Compounds containing beta-lactams | |
US4242262A (en) | 9-Nitromethyldeoxyclavulanic acid derivatives preparation and compositions | |
GB1504426A (en) | Clavulanic acid derivatives | |
US4303665A (en) | Methylaminodeoxy-clavulanic acid derivatives, their production and use | |
IT1036078B (en) | Beta-Lactam antibiotic combination preparations - contg a 7-tetrazolylacetamido-cephem cpd and penicillin | |
CA1068603A (en) | Preparations comprising phosphonomycin and another antibiotic | |
US4036969A (en) | 2,12-Dioxo-7-hydroxymethyl-9-phenyl-1-aza-5,8,11-trioxotetracyclo[9.2.0.06,13 0.6.9 ]tridecane | |
ES8301236A1 (en) | Chemical compound | |
EP0007717B1 (en) | Clavulanic acid derivatives, a process for their preparation, their use, and pharmaceutical compositions containing them |
Date | Code | Title | Description |
---|---|---|---|
PS | Patent sealed | ||
704A | Declaration that licence is not available as of right for an excepted use (par. 4a/1977) | ||
PE20 | Patent expired after termination of 20 years | Effective date:19950410 |